Pharma Journalist -

Innovus Pharmaceuticals announced today that the Company has acquired four branded topical products from Boston Topicals, expanding its retail and e-commerce presence in the Company’s…
Read More...

Merck KGaA, Darmstadt, Germany and software company Palantir Technologies announced their intent to form a joint venture under the brand name Syntropy. Syntropy is expected to empower…
Read More...

Roivant Sciences and iNtRON Biotechnology announced that they have entered into a global licensing agreement for SAL200, a novel investigational biologic for the treatment of infectious…
Read More...

CASI Pharmaceuticals announces that it has entered into framework agreements to build a state-of-the-art manufacturing site strategically located in the Wuxi Huishan Economic…
Read More...

DirectBiologics, LLC announces the acquisition of Paisley Laboratories, LLC. The mission of these combined research and development companies is to transform regenerative healing with…
Read More...

In the lead up the 3rd Microbiome Movement – Drug Development Europe 2019 in Paris this coming January (28 -30), we’re delighted to announce that Microbiotica, a leading player in…
Read More...

Boehringer Ingelheim and Epizyme announced a new global collaboration focused on the research, development and commercialization of novel small molecule inhibitors directed toward two…
Read More...

Seattle Genetics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to ADCETRIS (brentuximab vedotin) for previously untreated…
Read More...

Mission Therapeutics and AbbVie announced a collaboration in the research and preclinical development of specified DUB inhibitors for the treatment of Alzheimer’s Disease and…
Read More...

AstraZeneca has agreed to sell US rights to Synagis (palivizumab) used for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (RSV)…
Read More...